Study Comparing Ticagrelor With Aspirin for Prevention of Vascular Events in Patients Undergoing CABG
A phase 3 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 1893 participants.
Also called NCT01755520
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 1,893 participants
- Registry
-
NCT01755520 -
2012-003630-16
-
- Other papers using this trial's data
- Randomized trial of ticagrelor vs. aspirin in patients after coronary artery bypass grafting: the TiCAB trial
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Austria, Germany, Switzerland
- Registry status
- Terminated
Technical summary
Registry record NCT01755520. Randomized; quadruple masking; primary purpose treatment. Start 2013-04-24 (registry gives no type); primary completion 2018-05-19 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Study Comparing Ticagrelor With Aspirin for Prevention of Vascular Events in Patients Undergoing CABG
- Acronym
- TiCAB
- Condition
- Coronary Artery Disease
- Condition
- Stable Angina
- Condition
- Acute Coronary Syndrome
- Intervention (Drug)
- Ticagrelor
- Intervention (Drug)
- Aspirin
- Intervention (Drug)
- Placebo - Ticagrelor
- Intervention (Drug)
- Placebo - Aspirin
- Lead sponsor
- Deutsches Herzzentrum Muenchen
- Collaborator
- AstraZeneca
Record details
- Record id
cardio:ct-nct01755520- Content hash
607b2f3427771a18557ad32a07a0682afdd4f3f33bdd9f32aff18363870a25da